Results 81 to 90 of about 11,686 (228)

Prophylactic hyperthermic intraperitoneal chemotherapy is associated with improved disease-free survival in pathologic T4 colorectal cancer: a propensity score–matched cohort study

World Journal of Surgical Oncology
Background Pathologic T4 colorectal cancer (CRC) carries a high risk of peritoneal recurrence despite curative resection. Early postoperative hyperthermic intraperitoneal chemotherapy (HIPEC) may enhance intraperitoneal cytotoxic exposure and improve ...
Rongpeng Chen, Sihan Hu, Zhicheng Feng, Feng Xiao, Guoqiang Wang   +4 more
doaj   +1 more source

Anastomosis versus rectal stump procedure in cytoreductive surgery with hyperthermic intraperitoneal chemotherapy for colorectal and appendiceal peritoneal metastases: A comparative study

Colorectal Disease, Volume 27, Issue 10, October 2025.
Abstract Aim Cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC) is the standard treatment for peritoneal metastases (PM) of colorectal or appendiceal origin. Rectal anastomotic leakage (RAL) or rectal stump blow‐out is a serious complication following rectal resection after CRS‐HIPEC. This study aimed to compare outcomes
Lana Ghanipour, Lana Othman Mahmmud, Peter Cashin, Gabriella Jansson Palmer, Mirna Abraham‐Nordling   +4 more
wiley   +1 more source

Prophylactic HIPEC with radical D2 gastrectomy improves survival and peritoneal recurrence rates for locally advanced gastric cancer: personal experience from a randomized case control study

BMC Cancer, 2019
Background To investigate the implications of prophylactic intraoperative Hyperthermic Intraperitoneal Chemotherapy (HIPEC) with D2 radical gastrectomy for locally advanced Gastric Cancer (AGC) in a randomized case control study.
Maneesh Kumarsing Beeharry, Zheng-Lun Zhu, Wen-Tao Liu, Xue-Xin Yao, Min Yan, Zheng-Gang Zhu   +5 more
doaj   +1 more source

Peritoneal carcinomatosis from gastric cancer: a multi-institutional study of 159 patients treated by cytoreductive surgery combined with perioperative intraperitoneal chemotherapy [PDF]

, 2010
BACKGROUND: Peritoneal carcinomatosis (PC) from gastric cancer has long been regarded a terminal disease with a short median survival. New locoregional therapeutic approaches combining cytoreductive surgery with perioperative intraperitoneal chemotherapy
Association Française de Chirurgie (AFC), B. Mansvelt, C. Arvieux, D. Elias, E. Cotte, F. Boutitie, F. Quenet, F.Noel Gilly, G. Lorimier, J.Marc Bereder, O. Glehen   +10 more
core   +2 more sources

HIPEC Ca Ορθού

, 2021
Globally colorectal cancer is the third most common cancer and ranks as the fourth most common cancer related mortality. The American Cancer Society (ACS) estimates that 97,220 new cases of colon cancer and 43,030 new cases of rectal cancer will occur in 2018; 25,920 cases of rectal cancer are expected in men and 17,110 in women accordingly ...
openaire   +1 more source

Adjuvant HIPEC for gastric cancer [PDF]

Journal of Gastrointestinal Oncology, 2021
Paul H, Sugarbaker, Kurt, Van der Speeten   +1 more
openaire   +2 more sources

Heating technology for malignant tumors: a review

International Journal of Hyperthermia, 2020
The therapeutic application of heat is very effective in cancer treatment. Both hyperthermia, i.e., heating to 39–45 °C to induce sensitization to radiotherapy and chemotherapy, and thermal ablation, where temperatures beyond 50 °C destroy tumor cells ...
H. Petra Kok, Erik N. K. Cressman, Wim Ceelen, Christopher L. Brace, Robert Ivkov, Holger Grüll, Gail ter Haar, Peter Wust, Johannes Crezee   +8 more
doaj   +1 more source

HIPEC ir citoredukcinių operacijų patirtis

Sveikatos mokslai, 2013
The aim of the study is to summarize our first experience in cytoreductive surgery(CRS) combined with intraoperative intraperitoneal chemotherapy (HIPEC) in Klaipeda University hospital. Patients and methods. A retrospective analysis of our first 10 patients who were treated with cytoreductive surgery combined with hyperthermic intraperitoneal ...
Vitalijus Eismontas, Vaidotas Turskis, Alvydas Česas, Algirdas Šlepavičius   +3 more
openaire   +1 more source

Aerosolization of nanotherapeutics as a newly emerging treatment regimen for peritoneal carcinomatosis

, 2019
Recent advances in locoregional chemotherapy have opened the door to new approaches for the clinical management of peritoneal carcinomatosis (PC) by facilitating the delivery of anti-neoplastic agents directly to the tumor site, while mitigating adverse ...
Ceelen, Wim, De Smedt, Stefaan, Remaut, Katrien, Shariati, Molood, Willaert, Wouter   +4 more
core   +1 more source

Mesotelioma peritoneal. A propósito de un caso [PDF]

, 2019
El mesotelioma peritoneal maligno difuso (MPM) es una neoplasia de infrecuente aparición que surge de las células mesoteliales del peritoneo. Tiene una incidencia aproximada de 2500 casos al año a escala mundial.
Calderón Martínez, Gonzalo
core